Usage: NITYR® is indicated for treating adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1), in conjunction with a diet that restricts tyrosine and phenylalanine.
Usage: ORFADIN® is indicated for treating adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1), alongside dietary restriction of tyrosine and phenylalanine.
Usage: ORFADIN® is indicated for treating adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1), and it should be used alongside a diet that restricts tyrosine and phenylalanine intake.